Artificial Intelligence (AI) in Medical Imaging Market by Component(Hardware, Software, Service), Modality (MRI, CT, X-Ray), Application (Radiology, Cardio, Cancer- Lung, Breast, Prostate), End User(Hospital, Imaging Center) - Global Forecast to 2029

icon1
USD 1.6 BN
MARKET SIZE, 2029
icon2
CAGR 0.232%
(2024-2029)
icon3
430
REPORT PAGES
icon4
520
MARKET TABLES

OVERVIEW

Artificial Intelligence (AI) in Medical Imaging Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global AI medical imaging market is expected to grow with a strong CAGR of 23.2%. It will increase from around USD 1.5 billion in 2024 to USD 4.5 billion by 2029. The market is witnessing exponential growth, driven by rapid advances in deep learning algorithms, cloud-based deployment, and the integration of multimodal imaging data into diagnostic workflows. The expanding adoption of AI across radiology, oncology, cardiology, and neurology is redefining the speed, accuracy, and efficiency of image interpretation. AI models now serve as intelligent assistants to radiologists—detecting early-stage lesions, quantifying disease progression, and reducing reporting turnaround time. Moreover, the increasing integration of AI with PACS, RIS, and enterprise imaging platforms is transforming traditional imaging workflows into end-to-end automated ecosystems.

KEY TAKEAWAYS

  • By Region
    The North America AI in medical imaging market accounted for a 37.9% revenue share in 2024.
  • By Component
    By product type, the services segment is expected to register the highest CAGR of 32.2%.
  • By Application
    By age group, the radiology segment is projected to grow at the fastest rate from 2025 to 2030.
  • By Modality
    By modality form, the CT segment is expected to dominate the market.
  • By End-user
    By end-user, the Hospitals segment will grow the fastest during the forecast period.

AI adoption has transitioned from proof-of-concept pilots to enterprise-wide clinical deployments. The trend toward multi-disease AI platforms, foundation models, and cloud-based federated learning is reshaping vendor strategies. The use of large multimodal datasets—combining radiomics, genomics, and clinical data—is enabling more predictive and personalized diagnostic insights. Meanwhile, regulatory approvals for AI algorithms by the FDA, CE, and Japan’s PMDA are accelerating market maturity. Additionally, AI-driven triage, decision support, and workflow automation tools are now being bundled into modality sales by OEMs like GE Healthcare, Siemens Healthineers, and Philips, underscoring the convergence of hardware and software value.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Hospitals and diagnostic networks are facing a paradigm shift as AI democratizes image interpretation, enabling workload redistribution and decision support for non-radiologist clinicians. The rise of AI-enabled teleradiology and cloud-native imaging repositories allows real-time collaboration across distributed networks. Emerging disruptions include the integration of generative AI for report drafting, zero-click automation for lesion quantification, and predictive analytics for patient stratification and treatment planning. Vendors are also embedding AI into ultrasound and portable imaging systems, enhancing diagnostic access in community and rural setting

Artificial Intelligence (AI) in Medical Imaging Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Influx of big with increasing digitization and adoption of information systems
  • Growing cross-industry partnerships & collaborations
RESTRAINTS
Impact
Level
  • Reluctance among medical practitioners to adopt AI-based technologies
  • Inadequate AI workforce and ambiguous regulatory guidelines for medical software
OPPORTUNITIES
Impact
Level
  • Untapped emerging markets
  • Increasing focus on developing human-aware AI systems
CHALLENGES
Impact
Level
  • Budgetary constraints
  • Unstructured healthcare data due to growing digital footprint and technology trends

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Influx of big with increasing digitization and adoption of information systems

With the increasing digitization and adoption of information systems in the healthcare industry, big data (large and complex data) is generated at various stages of the care delivery process. In the medical imaging industry, big data includes information generated from clickstream and web & social media interactions; readings from medical devices, such as sensors, ECGs, X-rays, healthcare claims, and other billing records; and biometric data. Big data and analytical solutions have grown exponentially in sophistication and adoption in the last decade with the growing adoption of EHRs, digitized laboratory slides, and high-resolution radiology images among healthcare providers.

Restraint: Reluctance among medical practitioners to adopt AI-based technologies

Extensive growth in digital health has enabled healthcare providers to assist patients through novel treatment approaches. AI technologies offer doctors tools that help them diagnose and effectively treat patients better. However, there is an observed reluctance among doctors to accept new technologies. For instance, medical practitioners have a misconception that AI will replace doctors in the coming years. Doctors and radiologists believe that empathy and persuasion are human skills; thus, technologies cannot completely rule out the presence of a doctor. Additionally, there is a concern that patients may be excessively inclined toward these technologies and may forgo necessary in-person treatments, which might also challenge long-term doctor-patient relationships.

Opportunity: Untapped emerging market

Emerging markets such as India, China, and Brazil are expected to offer significant growth opportunities for players operating in the AI in medical imaging market. This can be attributed to the rising patient population in these countries. The National Institute of Health and Family Welfare estimates that there are between 2 and 2.5 million cancer patients in India at any given time. Each year, approximately 700,000 new cases of cancer are reported in the country. Furthermore, the healthcare sectors in emerging economies, such as India and China, are rapidly growing by introducing new medical technologies with a particular focus on advanced imaging equipment. These factors and the growing population are expected to increase the medical imaging data volumes in their respective healthcare systems. This provides an untapped development opportunity for AI-based solutions in emerging countries

Challenge: Budgetary constraints

Overcoming financial constraints is the biggest challenge for healthcare organizations, specifically in emerging economies where it is always a struggle to secure budgets for IT over medical equipment. The high cost of imaging equipment and implementation & licensing costs of AI software are crucial in restraining market growth, specifically in countries where the reimbursement scenario is poor. For instance, most healthcare facilities in developing countries cannot afford AI solutions due to high installation and maintenance costs. This factor limits the adoption of new or technologically advanced systems. Also, implementation and subscription/licensing fees form a significant financial burden on end users. Small healthcare facilities cannot afford these solutions due to these budget constraints, thus negatively impacting the growth of the AI in medical imaging market.

Artificial Intelligence (AI) in Medical Imaging Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
AI-powered image reconstruction for MRI and CT scans (e.g., Deep Resolve). Reduces scan time by up to 50%, improves image clarity, enhances patient throughput.
AI algorithms for automated lesion detection and quantification in oncology imaging. Speeds up diagnosis, supports early cancer detection, reduces radiologist workload.
AI-assisted workflow and triage in radiology systems (IntelliSpace AI Workflow Suite). Streamlines case prioritization, increases diagnostic accuracy, improves reporting efficiency.
Deep learning-based triage for emergency radiology (CT scans for stroke, PE, etc.). Real-time alerts for critical findings, faster clinical decisions, improved patient outcomes.
AI analytics platform detecting multiple diseases from standard medical imaging. Scalable population screening, early disease identification, cost-efficient healthcare delivery.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem spans a diverse network of AI software developers, imaging OEMs, cloud providers, healthcare IT vendors, and academic institutions. Tier I OEMs such as GE Healthcare, Siemens Healthineers, Philips, and Canon Medical are embedding AI into their imaging systems. Meanwhile, software innovators like Aidoc, Arterys, Gleamer, Viz.ai, and Qure.ai are focusing on disease-specific algorithms for stroke, lung, and oncology applications. Partnerships with cloud and data infrastructure providers (AWS, Google Cloud, Microsoft Azure) are enabling scalable deployments. Integration partners, imaging analytics firms, and radiology groups are collectively driving ecosystem maturity.

Artificial Intelligence (AI) in Medical Imaging Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Artificial Intelligence (AI) in Medical Imaging Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

AI in Medical Imaging Market, By Modality

CT imaging dominates the AI in medical imaging market, accounting for the largest revenue share due to its critical role in oncology, neurology, and cardiovascular diagnostics. The high image density of CT scans makes them ideal for AI-driven lesion detection and quantitative analysis. MRI is the second-largest modality, driven by increasing use of AI in image reconstruction and motion correction. Meanwhile, ultrasound AI is the fastest-growing segment, propelled by handheld ultrasound adoption and AI-enabled point-of-care diagnostics.

AI in Medical Imaging Market, By Application

Oncology imaging leads the market, given the growing need for early tumor detection, treatment response monitoring, and radiomics-based biomarkers. Neurology is another major segment, driven by AI use in detecting stroke, dementia, and traumatic brain injuries. Cardiology AI applications are expanding rapidly with increasing adoption of echocardiography and CT angiography tools that leverage AI for plaque and function quantification.

AI in Medical Imaging Market, By End User

Hospitals and diagnostic imaging centers are the dominant end users, accounting for over 65% of market revenue, as they serve as primary adopters of enterprise-grade AI tools. Teleradiology service providers are emerging as high-growth users, leveraging AI for workflow prioritization and remote diagnostics. Research institutions and academic centers continue to contribute through algorithm development and validation studies.

REGION

North America to be fastest-growing region in global aerospace materials market during forecast period

North America remains the largest regional market, underpinned by strong regulatory support (FDA clearances), robust AI vendor ecosystems, and early adoption across integrated healthcare networks. The presence of key players and cloud infrastructure maturity further boosts market penetration. In contrast, Asia-Pacific is the fastest-growing region due to government-backed digital health programs, rising imaging volumes, and local innovation hubs in China, India, Japan, and South Korea. Rapid investments in AI-powered diagnostic infrastructure and growing medical tourism are further accelerating adoption

Artificial Intelligence (AI) in Medical Imaging Market Region

Artificial Intelligence (AI) in Medical Imaging Market: COMPANY EVALUATION MATRIX

The competitive landscape is moderately consolidated, with a mix of global OEMs and agile software innovators. Tier I leaders (GE Healthcare, Siemens Healthineers, Philips, Canon Medical) dominate through integrated AI ecosystems embedded into their imaging systems. Tier II firms (Aidoc, Arterys, Qure.ai, Gleamer, Viz.ai) are disrupting the market through agile, cloud-native, disease-specific algorithms. The future competitive differentiation will hinge on model explainability, interoperability, and clinical validation breadth. Emerging trends in AI marketplaces, open AI platforms, and vendor-neutral integration layers are expected to further redefine the competitive dynamics by 2030.

Artificial Intelligence (AI) in Medical Imaging Market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 1.5 Billion
Market Forecast in 2030 (Value) USD 4.5 Billion
Growth Rate CAGR of 23.2% from 2025-2030
Years Considered 2022-2030
Base Year 2023
Forecast Period 2025-2030
Units Considered Value (USD Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Component:
    • Software
    • Services
    • Hardware
  • By Application:
    • Radiology
    • Oncology
    • Cardiology
    • Neurology
    • Obstetrics/gynecology
    • Orthopedics
    • Other applications
  • By Modality:
    • CT
    • MRI
    • X-Ray
    • Ultrasound
    • Mammography
    • Other Modalities
  • By End-users:
    • Hospitals & Surgical Centers
    • Diagnostics Imaging Centers
    • Other End User
Regions Covered North America, Asia Pacific, Europe, South America, Middle East & Africa

WHAT IS IN IT FOR YOU: Artificial Intelligence (AI) in Medical Imaging Market REPORT CONTENT GUIDE

Artificial Intelligence (AI) in Medical Imaging Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Leading Healthcare OEM
  • Competitive benchmarking of AI imaging solution providers (algorithms, modalities, regulatory approvals)
  • Assessment of integration trends with PACS/RIS systems
  • Partnership and supply chain mapping across hospitals and diagnostic centers
  • Identify leading AI vendors for collaboration
  • Detect performance gaps in current imaging systems
  • Highlight opportunities for improved diagnostic efficiency and workflow automation
AI Software Developer
  • Market adoption benchmarking across radiology, cardiology, oncology
  • Switching cost analysis for hospitals transitioning from manual to AI-assisted imaging
  • Application roadmap by imaging type (CT, MRI, Ultrasound, X-ray)
  • Insights on high-growth imaging modalities
  • Identify early-adopting hospital networks
  • Pinpoint regulatory and reimbursement enablers for market expansion
Medical Device Manufacturer
  • Technical & clinical benefit evaluation of AI-augmented imaging hardware
  • Forecast of AI integration levels in imaging devices by 2030
  • R&D landscape for hybrid imaging modalities (AI + real-time analytics)
  • Strengthen positioning in AI-enabled imaging platforms
  • Identify long-term innovation opportunities in diagnostic accuracy
  • Support entry into AI-driven imaging hardware ecosystem
Healthcare Data Provider
  • Global and regional AI medical imaging dataset availability mapping
  • Data licensing and anonymization benchmarking
  • Profiling of leading healthcare institutions for data partnerships
  • Identify high-demand AI data sources for training models
  • Enable compliance-ready data sharing frameworks
  • Strengthen partnerships for data commercialization
Hospital Network / Diagnostic Chain
  • ROI and performance benchmarking for AI imaging deployments
  • Workflow efficiency analysis
  • Comparative evaluation of AI tools for specific use-cases (oncology, neurology, cardiology)
  • Quantify cost savings and throughput improvement
  • Optimize vendor selection
  • Accelerate adoption of AI for faster, more accurate diagnostics
Venture Capital / Investor
  • Investment landscape and M&A mapping in AI medical imaging startups
  • Pipeline assessment of AI imaging algorithms under FDA/CE approval
  • Valuation benchmarking of emerging AI companies
  • Identify high-potential investment targets
  • Evaluate technology readiness and clinical validation
  • Support strategic funding decisions for portfolio optimization

RECENT DEVELOPMENTS

  • July 2024 : Microsoft partnered with Mass General Brigham and the University of Wisconsin to enhance AI models for medical imaging, improving radiologist efficiency and patient outcomes
  • March 2024 : Microsoft (US) collaborated with NVIDIA(US), to combine Azure’s cloud and AI capabilities with NVIDIA’s DGX cloud and Clara suite aiming to accelerate innovations in medical imaging, diagnosis and patient care
  • July 2024 : GE Healthcare collaborated with AWS to create AI-driven healthcare models, optimizing workflows and boosting diagnostic accuracy
  • COLUMN 'A' SHOULD BE IN TEXT FORMAT AND NOT DATE FORMAT :

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
37
2
RESEARCH METHODOLOGY
 
 
 
43
3
EXECUTIVE SUMMARY
 
 
 
55
4
PREMIUM INSIGHTS
 
 
 
59
5
MARKET OVERVIEW
AI-driven healthcare revolutionizes diagnostics amid big data surge and strategic industry collaborations.
 
 
 
62
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
INFLUX OF BIG DATA WITH INCREASING DIGITIZATION AND ADOPTION OF INFORMATION SYSTEMS
 
 
 
 
5.2.1.2
GROWING CROSS-INDUSTRY PARTNERSHIPS & COLLABORATIONS
 
 
 
 
5.2.1.3
INCREASING DEMAND FOR AI-BASED SOLUTIONS TO REDUCE WORK PRESSURE ON RADIOLOGISTS
 
 
 
 
5.2.1.4
RISING GOVERNMENT INITIATIVES TO SUPPORT AI-BASED TECHNOLOGIES IN HEALTHCARE
 
 
 
 
5.2.1.5
AVAILABILITY OF EXTENSIVE FUNDING FOR AI-BASED STARTUPS
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
RELUCTANCE AMONG MEDICAL PRACTITIONERS TO ADOPT AI-BASED TECHNOLOGIES
 
 
 
 
5.2.2.2
INADEQUATE AI WORKFORCE AND AMBIGUOUS REGULATORY GUIDELINES FOR MEDICAL SOFTWARE
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
UNTAPPED EMERGING MARKETS
 
 
 
 
5.2.3.2
INCREASING FOCUS ON DEVELOPING HUMAN-AWARE AI SYSTEMS
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
BUDGETARY CONSTRAINTS
 
 
 
 
5.2.4.2
UNSTRUCTURED HEALTHCARE DATA DUE TO GROWING DIGITAL FOOTPRINT AND TECHNOLOGY TRENDS
 
 
 
 
5.2.4.3
DATA PRIVACY CONCERNS AMID GROWING DATA VOLUME
 
 
 
 
5.2.4.4
LIMITED INTEROPERABILITY FOR AI SOLUTIONS
 
 
5.3
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.4
CASE STUDY ANALYSIS
 
 
 
 
 
5.4.1
CASE STUDY 1: INTEGRATING AI INTO CLINICAL WORKFLOWS AT LAHEY HOSPITAL & MEDICAL CENTER
 
 
 
 
5.4.2
CASE STUDY 2: RESOLVING CHALLENGES OF UNDERSTAFFED WORKFORCE AND BACKLOG WITH VEYE LUNG NODULES
 
 
 
 
5.4.3
CASE STUDY 3: NVIDIA AI ENTERPRISE SOFTWARE AND GPUS HELP IMPROVE PERFORMANCE AND PRECISION OF TUMOR TARGETING
 
 
 
 
5.4.4
CASE STUDY 4: ZHEJIANG UNIVERSITY AND ZHEJIANG DE IMAGE SOLUTIONS USE INTEL AI SOLUTION TO PROCESS ULTRASOUND
 
 
 
 
5.4.5
CASE STUDY 5: WAITEMATA DISTRICT HEALTH BOARD PROJECT UTILIZES PRECISION-DRIVEN HEALTH SOLUTIONS
 
 
 
5.5
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
5.5.1
UPSTREAM
 
 
 
 
5.5.2
MID-STREAM
 
 
 
 
5.5.3
DOWNSTREAM
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
5.6.1
IMPORT DATA
 
 
 
 
5.6.2
EXPORT DATA
 
 
 
5.7
PORTER'S FIVE FORCES ANALYSIS
 
 
 
 
 
5.7.1
THREAT OF NEW ENTRANTS
 
 
 
 
5.7.2
THREAT OF SUBSTITUTES
 
 
 
 
5.7.3
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.7.4
BARGAINING POWER OF BUYERS
 
 
 
 
5.7.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.8
KEY STAKEHOLDERS & BUYING CRITERIA
 
 
 
 
 
 
5.8.1
INFLUENCE OF STAKEHOLDERS
 
 
 
 
5.8.2
BUYING CRITERIA
 
 
 
5.9
REGULATORY ANALYSIS
 
 
 
 
 
5.9.1
REGULATORY LANDSCAPE
 
 
 
 
 
5.9.1.1
NORTH AMERICA
 
 
 
 
5.9.1.2
EUROPE
 
 
 
 
5.9.1.3
ASIA PACIFIC
 
 
 
 
5.9.1.4
REST OF THE WORLD
 
 
 
5.9.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
5.10
PATENT ANALYSIS
 
 
 
 
 
 
5.10.1
PATENT PUBLICATION TRENDS FOR AI IN MEDICAL IMAGING
 
 
 
 
5.10.2
JURISDICTION AND TOP APPLICANT ANALYSIS
 
 
 
5.11
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.11.1
KEY TECHNOLOGIES
 
 
 
 
 
5.11.1.1
MACHINE LEARNING
 
 
 
 
5.11.1.2
DEEP LEARNING
 
 
 
5.11.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.11.2.1
LABORATORY AUTOMATION
 
 
 
 
5.11.2.2
EHR
 
 
 
5.11.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.11.3.1
NATURAL LANGUAGE PROCESSING
 
 
 
 
5.11.3.2
BIG DATA ANALYTICS
 
 
5.12
PRICING ANALYSIS
 
 
 
 
 
 
5.12.1
INDICATIVE PRICING ANALYSIS FOR AI IN MEDICAL IMAGING HARDWARE, 2021–2023
 
 
 
 
5.12.2
AVERAGE SELLING PRICE OF AI IN MEDICAL IMAGING HARDWARE, BY KEY PLAYER (2023)
 
 
 
 
5.12.3
AVERAGE SELLING PRICE, BY REGION (2023)
 
 
 
5.13
KEY CONFERENCES & EVENTS, 2025–2026
 
 
 
 
5.14
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
5.15
UNMET NEEDS ANALYSIS
 
 
 
 
5.16
END-USER EXPECTATIONS
 
 
 
 
5.17
REIMBURSEMENT SCENARIO
 
 
 
 
 
5.17.1
REIMBURSEMENT FOR AI SOFTWARE IN RADIOLOGY
 
 
 
5.18
INVESTMENT & FUNDING SCENARIO
 
 
 
 
6
AI IN MEDICAL IMAGING MARKET, BY COMPONENT
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 34 Data Tables
 
 
 
105
 
6.1
INTRODUCTION
 
 
 
 
6.2
SOFTWARE
 
 
 
 
6.3
SERVICES
 
 
 
 
 
6.3.1
GROWING FOCUS ON INTEGRATION OF AI SYSTEMS TO BOOST DEMAND
 
 
 
6.4
HARDWARE
 
 
 
 
 
6.4.1
PROCESSORS
 
 
 
 
 
6.4.1.1
MPU
 
 
 
 
6.4.1.2
GPU
 
 
 
 
6.4.1.3
FPGA
 
 
 
 
6.4.1.4
ASIC
 
 
 
6.4.2
MEMORY
 
 
 
 
 
6.4.2.1
DEVELOPMENT OF HIGH-BANDWIDTH MEMORY FOR AI APPLICATIONS TO DRIVE MARKET
 
 
 
6.4.3
NETWORKS
 
 
 
 
 
6.4.3.1
ADAPTERS
 
 
 
 
6.4.3.2
SWITCHES
 
 
 
 
6.4.3.3
INTERCONNECTS
 
7
AI IN MEDICAL IMAGING MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 26 Data Tables
 
 
 
137
 
7.1
INTRODUCTION
 
 
 
 
 
7.1.1
RADIOLOGY
 
 
 
 
 
7.1.1.1
ONCOLOGY
 
 
 
 
7.1.1.2
CARDIOLOGY
 
 
 
 
7.1.1.3
NEUROLOGY
 
 
 
 
7.1.1.4
OBSTETRICS/GYNECOLOGY
 
 
 
 
7.1.1.5
OPHTHALMOLOGY
 
 
 
 
7.1.1.6
OTHER APPLICATIONS
 
8
AI IN MEDICAL IMAGING MARKET, BY MODALITY
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 15 Data Tables
 
 
 
165
 
8.1
INTRODUCTION
 
 
 
 
 
8.1.1
COMPUTED TOMOGRAPHY (CT)
 
 
 
 
 
8.1.1.1
RISING AVAILABILITY OF CARDIAC CT DEVICES ENABLED WITH AI SOLUTIONS TO DRIVE MARKET
 
 
 
8.1.2
X-RAY
 
 
 
 
 
8.1.2.1
LAUNCH OF INNOVATIVE AI SOLUTIONS BY KEY PLAYERS TO DRIVE MARKET
 
 
 
8.1.3
MAGNETIC RESONANCE IMAGING (MRI)
 
 
 
 
 
8.1.3.1
RISING TECHNOLOGICAL ADVANCEMENTS TO FUEL UPTAKE
 
 
 
8.1.4
ULTRASOUND
 
 
 
 
 
8.1.4.1
INCREASING PREVALENCE OF OVARIAN CANCER TO BOOST DEMAND
 
 
 
8.1.5
MAMMOGRAPHY
 
 
 
 
 
8.1.5.1
RISING PREVALENCE OF BREAST CANCER TO DRIVE MARKET
 
 
 
8.1.6
OTHER MODALITIES
 
 
9
AI IN MEDICAL IMAGING MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 8 Data Tables
 
 
 
180
 
9.1
INTRODUCTION
 
 
 
 
9.2
HOSPITALS
 
 
 
 
 
9.2.1
HIGH PURCHASING POWER FOR ADVANCED AI DIAGNOSTIC IMAGING SOLUTIONS TO PROPEL MARKET
 
 
 
9.3
DIAGNOSTIC IMAGING CENTERS
 
 
 
 
 
9.3.1
INCREASING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO DRIVE MARKET
 
 
 
9.4
OTHER END USERS
 
 
 
10
AI IN MEDICAL IMAGING MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 12 Countries | 364 Data Tables.
 
 
 
189
 
10.1
INTRODUCTION
 
 
 
 
10.2
NORTH AMERICA
 
 
 
 
 
10.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
10.2.2
US
 
 
 
 
 
10.2.2.1
INCREASING NUMBER OF IMAGING PROCEDURES TO DRIVE MARKET
 
 
 
10.2.3
CANADA
 
 
 
 
 
10.2.3.1
RESEARCH GRANTS AND IMPROVED ACADEMICS IN RADIOLOGY TO DRIVE MARKET
 
 
10.3
EUROPE
 
 
 
 
 
10.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
10.3.2
GERMANY
 
 
 
 
 
10.3.2.1
RISING GOVERNMENT SUPPORT FOR PROMOTING ADOPTION OF AI IN MEDICAL IMAGING TO DRIVE MARKET
 
 
 
10.3.3
FRANCE
 
 
 
 
 
10.3.3.1
AVAILABILITY OF FUNDING FOR COMPANIES TO ENHANCE AI RESEARCH IN MEDICAL IMAGING
 
 
 
10.3.4
UK
 
 
 
 
 
10.3.4.1
INCREASING RADIOGRAPHY PROCEDURES TO DRIVE MARKET
 
 
 
10.3.5
ITALY
 
 
 
 
 
10.3.5.1
INCREASING DEMAND FOR EHRS AND EMRS DUE TO RISING GERIATRIC POPULATION TO DRIVE ADOPTION
 
 
 
10.3.6
SPAIN
 
 
 
 
 
10.3.6.1
GROWING AWARENESS REGARDING AI TO FAVOR MARKET GROWTH
 
 
 
10.3.7
REST OF EUROPE
 
 
 
10.4
ASIA PACIFIC
 
 
 
 
 
10.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
10.4.2
CHINA
 
 
 
 
 
10.4.2.1
RISING USE OF AI IN CLINICAL DECISION-MAKING TO DRIVE MARKET
 
 
 
10.4.3
JAPAN
 
 
 
 
 
10.4.3.1
STRONG HEALTHCARE INFRASTRUCTURE TO DRIVE UPTAKE OF ADVANCED AI SOLUTIONS
 
 
 
10.4.4
INDIA
 
 
 
 
 
10.4.4.1
FAVORABLE GOVERNMENT INITIATIVES FOR R&D INVESTMENTS TO DRIVE MARKET
 
 
 
10.4.5
REST OF ASIA PACIFIC
 
 
 
10.5
LATIN AMERICA
 
 
 
 
 
10.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
10.5.2
BRAZIL
 
 
 
 
 
10.5.2.1
HIGH TECHNOLOGICAL ADVANCEMENTS IN HEALTHCARE MARKET TO DRIVE MARKET
 
 
 
10.5.3
MEXICO
 
 
 
 
 
10.5.3.1
INVESTMENT INFLOWS AND INITIATIVES FOR AI-RELATED EDUCATION TO DRIVE MARKET
 
 
 
10.5.4
REST OF LATIN AMERICA
 
 
 
10.6
MIDDLE EAST & AFRICA
 
 
 
 
 
10.6.1
GCC COUNTRIES
 
 
 
 
 
10.6.1.1
RISING ADOPTION OF AI IN DIAGNOSTICS TO ELEVATE HEALTHCARE STANDARDS
 
 
 
10.6.2
REST OF MIDDLE EAST & AFRICA
 
 
11
COMPETITIVE LANDSCAPE
Discover key strategies driving market dominance in AI medical imaging and emerging competitive players.
 
 
 
345
 
11.1
OVERVIEW
 
 
 
 
11.2
KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2024
 
 
 
 
 
11.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN AI IN MEDICAL IMAGING MARKET
 
 
 
11.3
REVENUE ANALYSIS, 2019–2023
 
 
 
 
 
11.4
MARKET SHARE ANALYSIS, 2023
 
 
 
 
 
11.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
 
 
 
 
 
 
11.5.1
STARS
 
 
 
 
11.5.2
EMERGING LEADERS
 
 
 
 
11.5.3
PERVASIVE PLAYERS
 
 
 
 
11.5.4
PARTICIPANTS
 
 
 
 
11.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2023
 
 
 
 
 
11.5.5.1
COMPANY FOOTPRINT
 
 
 
 
11.5.5.2
REGIONAL FOOTPRINT
 
 
 
 
11.5.5.3
COMPONENT FOOTPRINT
 
 
 
 
11.5.5.4
APPLICATION FOOTPRINT
 
 
 
 
11.5.5.5
END-USER FOOTPRINT
 
 
11.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
 
 
 
 
 
 
11.6.1
PROGRESSIVE COMPANIES
 
 
 
 
11.6.2
RESPONSIVE COMPANIES
 
 
 
 
11.6.3
DYNAMIC COMPANIES
 
 
 
 
11.6.4
STARTING BLOCKS
 
 
 
 
11.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
 
 
 
 
 
11.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
11.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
11.7
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
11.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
11.9
COMPETITIVE SCENARIO
 
 
 
 
 
11.9.1
PRODUCT LAUNCHES
 
 
 
 
11.9.2
DEALS
 
 
 
 
11.9.3
OTHER DEVELOPMENTS
 
 
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
366
 
12.1
KEY PLAYERS
 
 
 
 
 
12.1.1
MICROSOFT
 
 
 
 
 
12.1.1.1
BUSINESS OVERVIEW
 
 
 
 
12.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
12.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
12.1.1.4
MNM VIEW
 
 
 
12.1.2
NVIDIA CORPORATION
 
 
 
 
12.1.3
MERATIVE
 
 
 
 
12.1.4
GOOGLE (ALPHABET, INC.)
 
 
 
 
12.1.5
INTEL CORPORATION
 
 
 
 
12.1.6
SIEMENS HEALTHINEERS AG
 
 
 
 
12.1.7
GE HEALTHCARE
 
 
 
 
12.1.8
ADVANCED MICRO DEVICES, INC.
 
 
 
 
12.1.9
KONINKLIJKE PHILIPS N.V.
 
 
 
 
12.1.10
CANON MEDICAL SYSTEMS CORPORATION
 
 
 
 
12.1.11
FUJIFILM HOLDINGS CORPORATION
 
 
 
12.2
OTHER PLAYERS
 
 
 
 
 
12.2.1
HEARTFLOW, INC.
 
 
 
 
12.2.2
ENLITIC, INC.
 
 
 
 
12.2.3
AIDENCE
 
 
 
 
12.2.4
BUTTERFLY NETWORK, INC.
 
 
 
 
12.2.5
NANO-X IMAGING LTD.
 
 
 
 
12.2.6
VIZ.AI, INC.
 
 
 
 
12.2.7
QUIBIM
 
 
 
 
12.2.8
QURE.AI
 
 
 
 
12.2.9
THERAPIXEL
 
 
 
 
12.2.10
AIDOC
 
 
 
 
12.2.11
LUNIT, INC.
 
 
 
 
12.2.12
ECHONOUS, INC.
 
 
 
 
12.2.13
ICOMETRIX
 
 
 
 
12.2.14
BRAINOMIX
 
 
13
APPENDIX
 
 
 
424
 
13.1
DISCUSSION GUIDE
 
 
 
 
13.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
13.3
CUSTOMIZATION OPTIONS
 
 
 
 
13.4
RELATED REPORTS
 
 
 
 
13.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
USD EXCHANGE RATES
 
 
 
 
TABLE 2
FACTOR ANALYSIS
 
 
 
 
TABLE 3
RISK ASSESSMENT: AI IN MEDICAL IMAGING MARKET
 
 
 
 
TABLE 4
COMPANIES AND THEIR ROLES IN AI IN MEDICAL IMAGING MARKET
 
 
 
 
TABLE 5
AI IN MEDICAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 6
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AI IN MEDICAL DIAGNOSTICS
 
 
 
 
TABLE 7
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
 
 
 
 
TABLE 8
KEY BUYING CRITERIA FOR END USERS
 
 
 
 
TABLE 9
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 10
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 11
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 12
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 13
LIST OF PATENTS/PATENT APPLICATIONS IN AI IN MEDICAL IMAGING MARKET
 
 
 
 
TABLE 14
INDICATIVE PRICING ANALYSIS OF PROCESSORS, BY REGION, 2021–2023 (USD)
 
 
 
 
TABLE 15
AVERAGE SELLING PRICE OF AI IN MEDICAL IMAGING HARDWARE, BY KEY PLAYER (2023)
 
 
 
 
TABLE 16
AVERAGE SELLING PRICE OF PROCESSORS, BY REGION, 2023
 
 
 
 
TABLE 17
AI IN MEDICAL IMAGING MARKET: KEY CONFERENCES & EVENTS, 2025–2026
 
 
 
 
TABLE 18
AI IN MEDICAL IMAGING MARKET: UNMET NEEDS
 
 
 
 
TABLE 19
AI IN MEDICAL IMAGING MARKET: END-USER EXPECTATIONS
 
 
 
 
TABLE 20
SELECTED AI DEVICES THAT ARE REIMBURSED BY US MEDICARE
 
 
 
 
TABLE 21
DIABETIC RETINOPATHY DIAGNOSIS CODING AND REIMBURSEMENT
 
 
 
 
TABLE 22
AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 23
AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 24
AI IN MEDICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 25
AI IN MEDICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 26
AI IN MEDICAL IMAGING SERVICES MARKET, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 27
AI IN MEDICAL IMAGING SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 28
AI IN MEDICAL IMAGING HARDWARE MARKET, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 29
AI IN MEDICAL IMAGING HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 30
AI IN MEDICAL IMAGING HARDWARE MARKET, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 31
AI IN MEDICAL IMAGING HARDWARE MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 32
AI IN MEDICAL IMAGING MARKET FOR HARDWARE PROCESSORS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 33
AI IN MEDICAL IMAGING MARKET FOR HARDWARE PROCESSORS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 34
AI IN MEDICAL IMAGING MARKET FOR HARDWARE PROCESSORS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 35
AI IN MEDICAL IMAGING MARKET FOR HARDWARE PROCESSORS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 36
AI IN MEDICAL IMAGING MARKET FOR MPU, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 37
AI IN MEDICAL IMAGING MARKET FOR MPU, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 38
AI IN MEDICAL IMAGING MARKET FOR GPU, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 39
AI IN MEDICAL IMAGING MARKET FOR GPU, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 40
AI IN MEDICAL IMAGING MARKET FOR FPGA, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 41
AI IN MEDICAL IMAGING MARKET FOR FPGA, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 42
AI IN MEDICAL IMAGING MARKET FOR ASIC, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 43
AI IN MEDICAL IMAGING MARKET FOR ASIC, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 44
AI IN MEDICAL IMAGING MARKET FOR HARDWARE MEMORY, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 45
AI IN MEDICAL IMAGING MARKET FOR HARDWARE MEMORY, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 46
AI IN MEDICAL IMAGING MARKET FOR HARDWARE NETWORKS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 47
AI IN MEDICAL IMAGING MARKET FOR HARDWARE NETWORKS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 48
AI IN MEDICAL IMAGING MARKET FOR HARDWARE NETWORKS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 49
AI IN MEDICAL IMAGING MARKET FOR HARDWARE NETWORKS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 50
AI IN MEDICAL IMAGING MARKET FOR ADAPTERS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 51
AI IN MEDICAL IMAGING MARKET FOR ADAPTERS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 52
AI IN MEDICAL IMAGING MARKET FOR SWITCHES, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 53
AI IN MEDICAL IMAGING MARKET FOR SWITCHES, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 54
AI IN MEDICAL IMAGING MARKET FOR INTERCONNECTS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 55
AI IN MEDICAL IMAGING MARKET FOR INTERCONNECTS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 56
AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 57
AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 58
AI IN MEDICAL IMAGING MARKET FOR RADIOLOGY APPLICATIONS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 59
AI MEDICAL IMAGING MARKET FOR RADIOLOGY APPLICATIONS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 60
AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 61
AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 62
AI IN MEDICAL IMAGING MARKET FOR BREAST CANCER, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 63
AI IN MEDICAL IMAGING MARKET FOR BREAST CANCER, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 64
AI IN MEDICAL IMAGING MARKET FOR LUNG CANCER, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 65
AI IN MEDICAL IMAGING MARKET FOR LUNG CANCER, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 66
AI IN MEDICAL IMAGING MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 67
AI IN MEDICAL IMAGING MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 68
AI IN MEDICAL IMAGING MARKET FOR PROSTATE CANCER, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 69
AI IN MEDICAL IMAGING MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 70
AI IN MEDICAL IMAGING MARKET FOR OTHER CANCERS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 71
AI IN MEDICAL IMAGING MARKET FOR OTHER CANCERS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 72
AI IN MEDICAL IMAGING MARKET FOR CARDIOLOGY APPLICATIONS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 73
AI IN MEDICAL IMAGING MARKET FOR CARDIOLOGY APPLICATIONS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 74
AI IN MEDICAL IMAGING MARKET FOR NEUROLOGY APPLICATIONS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 75
AI IN MEDICAL IMAGING MARKET FOR NEUROLOGY APPLICATIONS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 76
AI IN MEDICAL IMAGING MARKET FOR OBSTETRICS/GYNECOLOGY APPLICATIONS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 77
AI IN MEDICAL IMAGING MARKET FOR OBSTETRICS/GYNECOLOGY APPLICATIONS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 78
AI IN MEDICAL IMAGING MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 79
AI IN MEDICAL IMAGING MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 80
AI IN MEDICAL IMAGING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 81
AI IN MEDICAL IMAGING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 82
AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 83
AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 84
AI IN MEDICAL IMAGING MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 85
AI IN MEDICAL IMAGING MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 86
AI IN MEDICAL IMAGING MARKET FOR X-RAY, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 87
AI IN MEDICAL IMAGING MARKET FOR X-RAY, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 88
AI IN MEDICAL IMAGING MARKET FOR MRI, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 89
AI IN MEDICAL IMAGING MARKET FOR MRI, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 90
AI IN MEDICAL IMAGING MARKET FOR ULTRASOUND, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 91
AI IN MEDICAL IMAGING MARKET FOR ULTRASOUND, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 92
FDA-APPROVED AI APPLICATIONS IN BREAST IMAGING
 
 
 
 
TABLE 93
AI IN MEDICAL IMAGING MARKET FOR MAMMOGRAPHY, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 94
AI IN MEDICAL IMAGING MARKET FOR MAMMOGRAPHY, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 95
AI IN MEDICAL IMAGING MARKET FOR OTHER MODALITIES, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 96
AI IN MEDICAL IMAGING MARKET FOR OTHER MODALITIES, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 97
AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 98
AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 99
AI IN MEDICAL IMAGING MARKET FOR HOSPITALS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 100
AI IN MEDICAL IMAGING MARKET FOR HOSPITALS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 101
AI IN MEDICAL IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 102
AI IN MEDICAL IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 103
AI IN MEDICAL IMAGING MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 104
AI IN MEDICAL IMAGING MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 105
AI IN MEDICAL IMAGING MARKET, BY REGION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 106
AI IN MEDICAL IMAGING MARKET, BY REGION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 107
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 108
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 109
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 110
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 111
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 112
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 113
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 114
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 115
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 116
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 117
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 118
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 119
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 120
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 121
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 122
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 123
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 124
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 125
US: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 126
US: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 127
US: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 128
US: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 129
US: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 130
US: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 131
US: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 132
US: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 133
US: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 134
US: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 135
US: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 136
US: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 137
US: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 138
US: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 139
US: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 140
US: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 141
CANADA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 142
CANADA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 143
CANADA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 144
CANADA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 145
CANADA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 146
CANADA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 147
CANADA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 148
CANADA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 149
CANADA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 150
CANADA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 151
CANADA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 152
CANADA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 153
CANADA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 154
CANADA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 155
CANADA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 156
CANADA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 157
EUROPE: AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 158
EUROPE: AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 159
EUROPE: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 160
EUROPE: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 161
EUROPE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 162
EUROPE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 163
EUROPE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 164
EUROPE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 165
EUROPE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 166
EUROPE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 167
EUROPE: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 168
EUROPE: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 169
EUROPE: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 170
EUROPE: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 171
EUROPE: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 172
EUROPE: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 173
EUROPE: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 174
EUROPE: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 175
GERMANY: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 176
GERMANY: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 177
GERMANY: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 178
GERMANY: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 179
GERMANY: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 180
GERMANY: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 181
GERMANY: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 182
GERMANY: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 183
GERMANY: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 184
GERMANY: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 185
GERMANY: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 186
GERMANY: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 187
GERMANY: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 188
GERMANY: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 189
GERMANY: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 190
GERMANY: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 191
FRANCE: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 192
FRANCE: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 193
FRANCE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 194
FRANCE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 195
FRANCE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 196
FRANCE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 197
FRANCE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 198
FRANCE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 199
FRANCE: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 200
FRANCE: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 201
FRANCE: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 202
FRANCE: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 203
FRANCE: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 204
FRANCE: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 205
FRANCE: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 206
FRANCE: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 207
UK: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 208
UK: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 209
UK: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 210
UK: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 211
UK: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 212
UK: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 213
UK: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 214
UK: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 215
UK: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 216
UK: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 217
UK: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 218
UK: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 219
UK: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 220
UK: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 221
UK: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 222
UK: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 223
ITALY: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 224
ITALY: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 225
ITALY: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 226
ITALY: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 227
ITALY: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 228
ITALY: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 229
ITALY: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 230
ITALY: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 231
ITALY: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 232
ITALY: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 233
ITALY: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 234
ITALY: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 235
ITALY: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 236
ITALY: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 237
ITALY: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 238
ITALY: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 239
SPAIN: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 240
SPAIN: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 241
SPAIN: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 242
SPAIN: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 243
SPAIN: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 244
SPAIN: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 245
SPAIN: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 246
SPAIN: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 247
SPAIN: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 248
SPAIN: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 249
SPAIN: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 250
SPAIN: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 251
SPAIN: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 252
SPAIN: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 253
SPAIN: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 254
SPAIN: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 255
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 256
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 257
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 258
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 259
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 260
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 261
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 262
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 263
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 264
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 265
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 266
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 267
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 268
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 269
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 270
REST OF EUROPE: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 271
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 272
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 273
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 274
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 275
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 276
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 277
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 278
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 279
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 280
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 281
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 282
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 283
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 284
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 285
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 286
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 287
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 288
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 289
CHINA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 290
CHINA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 291
CHINA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 292
CHINA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 293
CHINA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 294
CHINA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 295
CHINA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 296
CHINA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 297
CHINA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 298
CHINA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 299
CHINA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 300
CHINA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 301
CHINA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 302
CHINA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 303
CHINA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 304
CHINA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 305
JAPAN: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 306
JAPAN: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 307
JAPAN: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 308
JAPAN: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 309
JAPAN: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 310
JAPAN: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 311
JAPAN: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 312
JAPAN: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 313
JAPAN: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 314
JAPAN: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 315
JAPAN: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 316
JAPAN: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 317
JAPAN: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 318
JAPAN: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 319
JAPAN: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 320
JAPAN: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 321
INDIA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 322
INDIA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 323
INDIA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 324
INDIA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 325
INDIA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 326
INDIA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 327
INDIA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 328
INDIA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 329
INDIA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 330
INDIA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 331
INDIA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 332
INDIA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 333
INDIA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 334
INDIA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 335
INDIA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 336
INDIA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 337
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 338
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 339
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 340
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 341
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 342
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 343
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 344
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 345
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 346
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 347
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 348
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 349
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 350
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 351
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 352
REST OF ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 353
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 354
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 355
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 356
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 357
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 358
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 359
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 360
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 361
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 362
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 363
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 364
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 365
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 366
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 367
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 368
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 369
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 370
LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 371
BRAZIL: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 372
BRAZIL: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 373
BRAZIL: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 374
BRAZIL: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 375
BRAZIL: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 376
BRAZIL: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 377
BRAZIL: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 378
BRAZIL: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 379
BRAZIL: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 380
BRAZIL: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 381
BRAZIL: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 382
BRAZIL: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 383
BRAZIL: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 384
BRAZIL: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 385
BRAZIL: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 386
BRAZIL: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 387
MEXICO: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 388
MEXICO: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 389
MEXICO: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 390
MEXICO: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 391
MEXICO: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 392
MEXICO: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 393
MEXICO: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 394
MEXICO: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 395
MEXICO: AI N MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 396
MEXICO: AI N MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 397
MEXICO: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 398
MEXICO: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 399
MEXICO: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 400
MEXICO: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 401
MEXICO: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 402
MEXICO: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 403
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 404
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 405
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 406
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 407
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 408
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 409
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 410
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 411
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 412
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 413
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 414
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 415
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 416
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 417
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 418
REST OF LATIN AMERICA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 419
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 420
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 421
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 422
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 423
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 424
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 425
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 426
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 427
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 428
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 429
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 430
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 431
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022(USD MILLION)
 
 
 
 
TABLE 432
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 433
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 434
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 435
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 436
MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 437
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 438
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 439
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 440
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 441
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 442
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 443
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 444
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 445
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 446
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 447
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 448
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 449
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 450
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 451
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 452
GCC COUNTRIES: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 453
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 454
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 455
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 456
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 457
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 458
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY PROCESSOR TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 459
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 460
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR HARDWARE COMPONENTS, BY NETWORK TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 461
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 462
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 463
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 464
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY TYPE, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 465
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 466
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 467
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2017–2022 (USD MILLION)
 
 
 
 
TABLE 468
REST OF MIDDLE EAST & AFRICA: AI IN MEDICAL IMAGING MARKET, BY END USER, 2023–2029 (USD MILLION)
 
 
 
 
TABLE 469
AI IN MEDICAL IMAGING MARKET: DEGREE OF COMPETITION, 2023
 
 
 
 
TABLE 470
AI IN MEDICAL IMAGING MARKET: REGIONAL FOOTPRINT
 
 
 
 
TABLE 471
AI IN MEDICAL IMAGING MARKET: COMPONENT FOOTPRINT
 
 
 
 
TABLE 472
AI IN MEDICAL IMAGING MARKET: APPLICATION FOOTPRINT
 
 
 
 
TABLE 473
AI IN MEDICAL IMAGING MARKET: END-USER FOOTPRINT
 
 
 
 
TABLE 474
AI IN MEDICAL IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
TABLE 475
AI IN MEDICAL IMAGING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
TABLE 476
AI IN MEDICAL IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
 
 
 
 
TABLE 477
AI IN MEDICAL IMAGING MARKET: DEALS, JANUARY 2021–DECEMBER 2024
 
 
 
 
TABLE 478
AI IN MEDICAL IMAGING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024
 
 
 
 
TABLE 479
MICROSOFT: COMPANY OVERVIEW
 
 
 
 
TABLE 480
MICROSOFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 481
MICROSOFT: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 482
MICROSOFT: DEALS, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 483
NVIDIA CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 484
NVIDIA CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 485
NVIDIA CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 486
NVIDIA CORPORATION: DEALS, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 487
MERATIVE: COMPANY OVERVIEW
 
 
 
 
TABLE 488
MERATIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 489
MERATIVE: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 490
MERATIVE: DEALS, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 491
MERATIVE: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 492
GOOGLE: COMPANY OVERVIEW
 
 
 
 
TABLE 493
GOOGLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 494
GOOGLE: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 495
GOOGLE: DEALS, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 496
INTEL CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 497
INTEL CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 498
INTEL CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 499
INTEL CORPORATION: DEALS, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 500
SIEMENS HEALTHINEERS: COMPANY OVERVIEW
 
 
 
 
TABLE 501
SIEMENS HEALTHINEERS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 502
SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 503
SIEMENS HEALTHINEERS: DEALS, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 504
GE HEALTHCARE: COMPANY OVERVIEW
 
 
 
 
TABLE 505
GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 506
GE HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 507
GE HEALTHCARE: DEALS, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 508
GE HEALTHCARE: EXPANSIONS, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 509
GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 510
ADVANCED MICRO DEVICES: COMPANY OVERVIEW
 
 
 
 
TABLE 511
ADVANCED MICRO DEVICES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 512
ADVANCED MICRO DEVICES: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 513
ADVANCED MICRO DEVICES: DEALS, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 514
KONINKLIJKE PHILIPS: COMPANY OVERVIEW
 
 
 
 
TABLE 515
KONINKLIJKE PHILIPS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 516
KONINKLIJKE PHILIPS: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 517
CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 518
CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 519
CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 520
CANON MEDICAL SYSTEMS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024
 
 
 
 
TABLE 521
FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 522
FUJIFILM HOLDINGS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 523
FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
AI IN MEDICAL IMAGING MARKET SEGMENTATION & REGIONAL SCOPE
 
 
 
 
FIGURE 2
RESEARCH DESIGN
 
 
 
 
FIGURE 3
PRIMARY SOURCES
 
 
 
 
FIGURE 4
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
FIGURE 5
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
 
 
 
 
FIGURE 6
MARKET SIZE ESTIMATION
 
 
 
 
FIGURE 7
AI IN MEDICAL IMAGING MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029)
 
 
 
 
FIGURE 8
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
 
 
 
 
FIGURE 9
TOP-DOWN APPROACH
 
 
 
 
FIGURE 10
DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 11
AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 12
AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 13
AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 14
AI IN MEDICAL IMAGING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 15
GEOGRAPHIC SNAPSHOT OF AI IN MEDICAL IMAGING MARKET
 
 
 
 
FIGURE 16
INFLUX OF BIG DATA AND ADOPTION OF INFORMATION SYSTEMS TO PROPEL MARKET
 
 
 
 
FIGURE 17
SOFTWARE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
 
 
 
 
FIGURE 18
ASIA PACIFIC REGION TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
 
 
 
FIGURE 19
ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
FIGURE 20
AI IN MEDICAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 21
AI IN MEDICAL IMAGING MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 22
AI IN MEDICAL IMAGING MARKET: VALUE CHAIN
 
 
 
 
FIGURE 23
IMPORT DATA FOR HS CODE 854231-COMPLIANT PRODUCTS FOR TOP COUNTRIES IN AI IN MEDICAL IMAGING MARKET, 2019–2023 (USD THOUSAND)
 
 
 
 
FIGURE 24
EXPORT DATA FOR HS CODE 854231-COMPLIANT PRODUCTS FOR TOP COUNTRIES IN AI IN MEDICAL IMAGING MARKET, 2019–2023 (USD THOUSAND)
 
 
 
 
FIGURE 25
AI IN MEDICAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 26
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
 
 
 
 
FIGURE 27
KEY BUYING CRITERIA FOR END USERS
 
 
 
 
FIGURE 28
ALGORITHMS CLEARED BY US FDA, 2008–2023
 
 
 
 
FIGURE 29
PATENT PUBLICATION TRENDS IN AI IN MEDICAL IMAGING MARKET, 2014–2024
 
 
 
 
FIGURE 30
PATENT ANALYSIS OF AI IN MEDICAL IMAGING MARKET, JANUARY 2014–AUGUST 2024
 
 
 
 
FIGURE 31
INDICATIVE PRICING ANALYSIS FOR AI IN MEDICAL IMAGING HARDWARE, 2021–2023
 
 
 
 
FIGURE 32
INDICATIVE PRICING ANALYSIS OF KEY PLAYERS, BY HARDWARE COMPONENT (2023)
 
 
 
 
FIGURE 33
AVERAGE SELLING PRICE OF PROCESSORS, BY REGION, 2023
 
 
 
 
FIGURE 34
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
FIGURE 35
NO. OF DEALS FOR KEY PLAYERS IN AI IN MEDICAL IMAGING MARKET, 2018–2022
 
 
 
 
FIGURE 36
DEAL VALUES FOR KEY PLAYERS IN AI IN MEDICAL IMAGING MARKET, 2018–2022
 
 
 
 
FIGURE 37
AI IN MEDICAL IMAGING MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 38
AI MEDICAL IMAGING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 39
NORTH AMERICA: AI IN MEDICAL IMAGING MARKET SNAPSHOT
 
 
 
 
FIGURE 40
ASIA PACIFIC: AI IN MEDICAL IMAGING MARKET SNAPSHOT
 
 
 
 
FIGURE 41
AI IN MEDICAL IMAGING MARKET: KEY STRATEGIES ADOPTED BY MAJOR PLAYERS, JANUARY 2021–DECEMBER 2024
 
 
 
 
FIGURE 42
REVENUE ANALYSIS OF KEY PLAYERS IN AI IN MEDICAL IMAGING MARKET, 2019–2023 (USD BILLION)
 
 
 
 
FIGURE 43
MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN MEDICAL IMAGING MARKET, 2023
 
 
 
 
FIGURE 44
AI IN MEDICAL IMAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
 
 
 
 
FIGURE 45
AI IN MEDICAL IMAGING MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 46
AI IN MEDICAL IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
 
 
 
 
FIGURE 47
AI IN MEDICAL IMAGING MARKET: EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 48
AI IN MEDICAL IMAGING MARKET: YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MEDICAL IMAGING SOLUTION VENDORS
 
 
 
 
FIGURE 49
AI IN MEDICAL IMAGING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
FIGURE 50
MICROSOFT: COMPANY SNAPSHOT
 
 
 
 
FIGURE 51
NVIDIA CORPORATION: COMPANY SNAPSHOT
 
 
 
 
FIGURE 52
GOOGLE: COMPANY SNAPSHOT
 
 
 
 
FIGURE 53
INTEL CORPORATION: COMPANY SNAPSHOT
 
 
 
 
FIGURE 54
SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
 
 
 
 
FIGURE 55
GE HEALTHCARE: COMPANY SNAPSHOT
 
 
 
 
FIGURE 56
ADVANCED MICRO DEVICES: COMPANY SNAPSHOT
 
 
 
 
FIGURE 57
KONINKLIJKE PHILIPS: COMPANY SNAPSHOT
 
 
 
 
FIGURE 58
CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
 
 
 
 
FIGURE 59
FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
 
 
 
 

Methodology

The scope for a well-balanced approach for both primary and secondary research about the AI in medical imaging market involved the review of many relevant variables for the small, medium-sized, and large enterprises. Direct engagement with experts from all across the industry value chain would take place, validating assumptions and findings during primary research for market size. This estimate was produced using a mix of several methodologies including a top-down and bottom-up approach. It studied significant market segments, evolving trends, regulatory frameworks, and competitive landscapes. It also considered market leaders and their strategies. Data triangulation was used at the end to finalize market size estimates, and primary research was used to validate the hypotheses.

Secondary Research

Secondary research relied on information derived from reputable sources, such as government publications, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva. These sources provided critical data on the technical, market-oriented, and commercial aspects of the AI in medical imaging market. Secondary data was analyzed to estimate the size of the market, and its accuracy was cross-checked through primary research.

Primary Research

Based on insights drawn from secondary sources, primary research was conducted to better understand the global AI in medical imaging market. Interviews were conducted with market participants from demand-side stakeholders such as hospitals, clinics, diagnostic laboratories, and imaging centers, as well as from supply-side participants including executives, product managers, marketing and sales managers from manufacturers, distributors, and channel partners. These interactions cut across key regions, including North America, Europe, Asia Pacific, and the Rest of the World. About 70% of the interviews involved supply-side experts, while 30% included demand-side participants. Data was collected through a combination of surveys, questionnaires, email correspondence, and telephonic and in-person interviews.

AI in Medical Imaging Market

Note 1: C-level primaries include CEOs, CFOs, and COOs.

Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note 3: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size of the global AI in medical imaging market was estimated based on a review of prominent companies and their revenue shares. Key players, who hold significant shares of the market, were identified through secondary research, and their respective revenue figures were calculated. The process involved analyzing the annual and financial reports of major market participants as part of secondary research. Additionally, in-depth interviews with key industry leaders, such as directors, CEOs, and marketing executives, were conducted as part of primary research.

Both top-down and bottom-up approaches were used to estimate and validate the size of the AI in medical imaging market and its associated submarkets. The research methodology used includes the following details:

  • Revenues of individual companies were gathered from public sources and databases.
  • Shares of the AI in medical imaging market players were gathered from secondary sources to the extent available. In certain cases, these shares were determined through a detailed analysis of parameters such as product portfolios, market positioning, pricing strategies, and geographic reach.
  • Individual shares or revenue estimates were validated through expert interviews.
  • Percentage shares, splits, and breakdowns for the global AI in medical imaging market were determined by secondary sources and verified through primary research.
  • All macroeconomic indicators influencing market revenue growth were extensively analyzed and validated through primary research, ensuring that both qualitative and quantitative data were accurately verified.
AI in Medical Imaging Market

Data Triangulation

The market size estimation of the overall market for AI in the medical imaging market followed a comprehensive market size estimation process. This process segmented the market into various segments and subsegments for better analysis. Data triangulation and market breakdown methodologies were used wherever applicable to ensure accuracy. This process included the assessment of various factors and trends from both demand and supply sides, which could help provide reliable and in-depth insights into the market. The AI in medical imaging market encompasses the use of artificial intelligence technologies to enhance, analyze, and interpret medical images in areas like radiology, oncology, cardiology, and other medical specialties, thereby enhancing diagnostic accuracy and patient care.

Market Definition

Artificial intelligence (AI) refers to the theory and development of computer systems capable of performing tasks that usually require human intelligence. AI involves the study & synthesis of intelligent agents—in this case, a computer system. The system perceives its environment and takes appropriate action to maximize success. AI is being developed to create expert systems and improve human intelligence in machines.

AI is used in the medical imaging market to analyze complex data from various imaging modalities and help end users interpret critical data points to diagnose conditions.

Stakeholders

  • Hospitals
  • Diagnostic care centers
  • Diagnostic laboratories
  • Radiologists and radiology clinics
  • Diagnostic imaging AI device manufacturers and suppliers
  • Medical research laboratories
  • Academic medical centers and universities

Report Objectives

  • To define, describe, and forecast artificial intelligence in the medical imaging market based on component, application, end-user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments concerning four main regions—North America, Europe, the Asia Pacific, and the Rest of the World (RoW)2
  • To profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches/enhancements, expansions, agreements, collaborations, partnerships, and approvals in AI medical imaging market

Key Questions Addressed by the Report

What is the projected market of the global AI in medical imaging market in 2029?
The AI in medical imaging market is projected to reach USD 4.54 billion by 2029.
Who are the leading players in the AI in medical imaging Market?
Some of the prominent players operating in the market are Microsoft (US), NVIDIA Corporation (US), Merative (US), Intel Corporation (US), Google (US), Siemens Healthineers (Germany), GE HealthCare (US), Digital Imaging Inc. (US), Advanced Micro Devices, Inc. (US), InformAI (US), HeartFlow, Inc. (US), Enlitic, Inc. (US), icometrix (Belgium), Aidence (Netherlands), Butterfly Network, Inc. (US), Nano-X Imaging LTD. (Israel), Viz.ai, Inc. (US), Quibim (Spain), Qure.ai (India), Therapixel (France), Aidoc (US), Koninklijke Philips N.V. (Netherlands), Lunit, Inc. (South Korea), EchoNous, Inc. (US), Brainomix (UK).
What are the major components of the AI in medical imaging market?
Software, hardware, and services are major components of the global AI in the medical imaging market. In 2023, the software segment accounted for the largest share of the AI in medical imaging market.
What are the applications of the AI in medical imaging Market?
Out of radiology, oncology, neurology, cardiology, OB/GYN, and ophthalmology applications in AI in medical imaging, the radiology segment commanded the largest share of this market in 2023
What are the key end users in the AI in medical imaging Market?
Out of the major end users, the AI in the medical imaging market, such as hospitals, diagnostic imaging centers, and other end users, the hospitals segment accounted for the largest market share in 2023.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Artificial Intelligence (AI) in Medical Imaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Artificial Intelligence (AI) in Medical Imaging Market

DMCA.com Protection Status